Protalix BioTherapeutics (PLX) Reports Q4 EPS of $0.02
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq hits near three-month low as Amazon, Intel deepen AI capex concerns
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil set for fourth monthly gain as Hormuz tanker attack highlights supply risks
| PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) | Delayed: 2.60 -0.01 (0.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.61 | 52 Week High | $1.11 | |||
| Open | $2.60 | 52 Week Low | $0.41 | |||
| Day High | $2.63 | P/E | N/A | |||
| Day Low | $2.58 | EPS | $-0.29 | |||
| Volume | 43,614 | |||||
